Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
BHVN · against 379 other Healthcare companies of similar size
Ranked #278 of 380 · scores higher than 6% of peers
Bars: peers in each 10-point band of the valuation score103 peers with a valuation score of 0–9, including BHVN · Click a bar to see the companies
Mainly because of its earnings yield, EBITDA yield and free cash flow yield, which are weaker than most Healthcare peers.
| Metric | BHVN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 370 reported | -29.3% | 2.0% | 2% | 30% | |
| EBITDA yieldHigher is better · 378 reported | -21.8% | 4.5% | 3% | 50% | |
| Free cash flow yieldHigher is better · 189 reported | -21.7% | -0.3% | 1% | 20% | |
| Book yieldHigher is better · 370 reported | 0.5% | 32.8% | 5% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 12.9B HKD (≈$1.7B) | 99 | 83 | |
| 1 | 226.3B JPY (≈$1.5B) | 99 | 77 | |
| 1 | 40.2B MXN (≈$2.2B) | 99 | 71 | |
| 278 | 2.9B USD | 8 | 44 | |
| 278 | 2.2B USD | 8 | 32 | |
| 278 | 2.7B USD | 8 | 50 | |
| 278 | 1.7B USD | 8 | 30 | |
| 278 | 2.4B USD | 8 | 6 | |
| 278 | 3.4B USD | 8 | 17 | |
| 278 | 2.3B USD | 8 | 25 | |
| 278 | 1.2B USD | 8 | ||
| 278 | 1.4B USD | 8 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score